MARKET

OSTX

OSTX

OS THERAPIES INCORPORATED
AMEX
1.810
+0.110
+6.47%
After Hours: 1.810 0 0.00% 16:05 05/13 EDT
OPEN
1.680
PREV CLOSE
1.700
HIGH
1.840
LOW
1.660
VOLUME
197.67K
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
1.120
MARKET CAP
39.21M
P/E (TTM)
-2.0580
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OSTX last week (0505-0509)?
Weekly Report · 1d ago
OS Therapies announces U.S. patent for Listeria immunotherapy platform
TipRanks · 6d ago
OS Therapies Inc trading resumes
TipRanks · 6d ago
OS Therapies Announces Issuance Of U.S. Patent Protecting Commercial Manufacturing Market Exclusivity For OST-HER2 In Rare Pediatric Cancer Osteosarcoma And Full Listeria Cancer Immunotherapy Platform Into 2040
Benzinga · 6d ago
OS Therapies Inc trading halted, news pending
TipRanks · 6d ago
Weekly Report: what happened at OSTX last week (0428-0502)?
Weekly Report · 05/05 12:35
Emmy-Winning Series Debuts Trailer for "Shelter Me: The Cancer Pioneers" Offering A Hopeful Look at Breakthrough Cancer Therapies
Barchart · 05/02 08:32
Weekly Report: what happened at OSTX last week (0421-0425)?
Weekly Report · 04/28 12:50
More
About OSTX
More
OS Therapies Incorporated is a clinical-stage oncology company focused on the identification, development, and commercialization of new class immunotherapy candidates for solid tumors, beginning with osteosarcoma and other solid tumors. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.
Recently
Symbol
Price
%Change
    FXL
  • 150.77
  • +2.04%

Webull offers OS Therapies Inc stock information, including AMEX: OSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OSTX stock methods without spending real money on the virtual paper trading platform.